Trial intelligence / Profile preview

Letrozole and Cetrotide vs Methotrexate for Ectopic Pregnancy

NCT04308343Unknown

Sponsor
Assiut University
Start
Mar 2020
Primary completion
Mar 2022
Modality
Peptides, Orthosteric Ligands
01

Overview

Randomised trial of letrozole and cetrorelix in Ectopic pregnancy (EP) (3 arms), sponsored by Assiut University. Primary endpoint: Achievement of resolution of ectopic pregnancy determined by serum hCG levels below laboratory immunoassay detection <15 IU/l at 3 months. Status: unknown.

02

Drugs

letrozolecetrorelix
03

Conditions

Ectopic pregnancy (EP)

Beyond the preview

Go deeper on NCT04308343.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04308343.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call